<s>
Thync	B-Device
is	O
a	O
venture-backed	O
startup	O
that	O
developed	O
a	O
non-invasive	O
,	O
neurostimulation	O
technology	O
that	O
targets	O
the	O
autonomic	O
nervous	O
system	O
.	O
</s>
<s>
In	O
2017	O
,	O
Thync	B-Device
exited	O
the	O
consumer	O
health	O
market	O
and	O
focused	O
all	O
efforts	O
on	O
the	O
development	O
of	O
a	O
bioelectronic	O
therapy	O
to	O
treat	O
moderate	O
psoriasis	O
.	O
</s>
